Lyra Therapeutics (LYRA) Short Interest Ratio & Short Volume $0.11 0.00 (-2.87%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.11 +0.00 (+3.42%) As of 05/2/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics Short Interest DataLyra Therapeutics (LYRA) has a short interest of 2.22 million shares, representing 3.56% of the float (the number of shares available for trading by the public). This marks a -7.88% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 2.06 million shares to cover all short positions.Current Short Interest2,220,000 sharesPrevious Short Interest2,410,000 sharesChange Vs. Previous Month-7.88%Dollar Volume Sold Short$204,684.00Short Interest Ratio1.9 Days to CoverLast Record DateApril 15, 2025Outstanding Shares65,881,000 sharesShort Percent of Float3.56%Today's Trading Volume1,399,926 sharesAverage Trading Volume2,061,989 sharesToday's Volume Vs. Average68% Short Selling Lyra Therapeutics? Sign up to receive the latest short interest report for Lyra Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYRA Short Interest Over TimeLYRA Days to Cover Over TimeLYRA Percentage of Float Shorted Over Time Lyra Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20252,220,000 shares $204,684.00 -7.9%3.6%1.9 $0.09 3/31/20252,410,000 shares $304,383.00 +0.4%3.9%2.2 $0.13 3/15/20252,400,000 shares $412,800.00 +27.7%3.8%2 $0.17 2/28/20251,880,000 shares $402,320.00 -13.4%3.0%1.5 $0.21 2/15/20252,170,000 shares $451,794.00 +1.4%3.5%1.5 $0.21 1/31/20252,140,000 shares $391,192.00 +0.5%N/A1.2 $0.18 1/15/20252,130,000 shares $402,570.00 +1.4%N/A1.1 $0.19 12/31/20242,100,000 shares $433,440.00 +14.1%N/A1.1 $0.21 12/15/20241,840,000 shares $335,984.00 -16.4%N/A1.1 $0.18 11/30/20242,200,000 shares $455,400.00 -7.6%N/A1.4 $0.21 Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/20242,380,000 shares $404,600.00 +16.7%N/A1.6 $0.17 10/31/20242,040,000 shares $560,796.00 -4.7%N/A2.1 $0.27 10/15/20242,140,000 shares $488,776.00 -24.9%N/A2.2 $0.23 9/30/20242,850,000 shares $732,450.00 -9.2%N/A3.2 $0.26 9/15/20243,140,000 shares $879,200.00 +6.1%N/A2.7 $0.28 8/31/20242,960,000 shares $952,232.00 -28.7%N/A2.3 $0.32 8/15/20244,150,000 shares $1.20 million +18.6%N/A2.7 $0.29 7/31/20243,500,000 shares $1.14 million -5.9%N/A1.7 $0.33 7/15/20243,720,000 shares $1.13 million +86.9%N/A1 $0.31 6/30/20241,990,000 shares $550,633.00 +28.4%N/A0.5 $0.28 6/15/20241,550,000 shares $457,560.00 +71.8%N/A0.4 $0.30 5/31/2024902,200 shares $295,921.60 +49.6%N/A0.3 $0.33 5/15/2024603,000 shares $214,547.40 +45.7%N/A0.2 $0.36 4/30/2024413,800 shares $2.14 million +24.0%N/A0.2 $5.16 4/15/2024333,600 shares $1.76 million +49.6%N/A1 $5.27 3/31/2024223,000 shares $1.39 million +8.1%N/A0.7 $6.22 3/15/2024206,300 shares $1.22 million +28.8%N/A0.8 $5.93 2/29/2024160,200 shares $842,652.00 -13.6%N/A0.6 $5.26 2/15/2024185,400 shares $927,000.00 +43.5%N/A0.8 $5.00 1/31/2024129,200 shares $587,860.00 -5.6%N/A0.6 $4.55 1/15/2024136,900 shares $736,522.00 -22.6%N/A0.6 $5.38 12/31/2023176,800 shares $926,432.00 +2.4%N/A0.9 $5.24 12/15/2023172,600 shares $802,590.00 -24.4%N/A0.7 $4.65 11/30/2023228,300 shares $755,673.00 -13.9%N/A0.6 $3.31 11/15/2023265,200 shares $766,428.00 -17.3%N/A0.7 $2.89 10/31/2023320,600 shares $952,182.00 +43.2%N/A0.9 $2.97 10/15/2023223,900 shares $801,562.00 -38.2%N/A0.6 $3.58 9/30/2023362,100 shares $1.42 million -14.0%N/A0.9 $3.91 9/15/2023421,100 shares $1.83 million +661.5%N/A1.2 $4.35 8/31/202355,300 shares $192,444.00 -19.5%N/A0.3 $3.48Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 8/15/202368,700 shares $245,946.00 -67.0%N/A0.4 $3.58 7/31/2023208,100 shares $670,082.00 -62.3%N/A1.1 $3.22 7/15/2023552,200 shares $1.69 million -0.1%N/A3.4 $3.06 6/30/2023552,600 shares $2.27 million +23.4%N/A4.2 $4.11 6/15/2023447,700 shares $1.34 million +56.8%N/A3.9 $2.99 5/31/2023285,500 shares $733,735.00 +1,513.0%N/A3.7 $2.57 5/15/202317,700 shares $46,197.00 -31.4%N/A0.5 $2.61 4/30/202325,800 shares $61,920.00 +27.1%N/A0.7 $2.40 4/15/202320,300 shares $48,517.00 +178.1%N/A0.6 $2.39 3/31/20237,300 shares $14,673.00 -29.1%N/A0.2 $2.01 3/15/202310,300 shares $21,012.00 -32.2%N/A0.3 $2.04 2/28/202315,200 shares $36,176.00 +22.6%N/A0.5 $2.38 2/15/202312,400 shares $30,256.00 +21.6%N/A0.4 $2.44 1/31/202310,200 shares $29,070.00 -21.5%N/A0.3 $2.85 1/15/202313,000 shares $36,010.00 -29.7%N/A0.2 $2.77 12/30/202218,500 shares $58,090.00 +44.5%N/A0.3 $3.14 12/15/202212,800 shares $34,944.00 -41.6%N/A0.2 $2.73 11/30/202221,900 shares $76,869.00 +0.5%N/A0.3 $3.51 11/15/202221,800 shares $85,020.00 No ChangeN/A0.3 $3.90 10/31/202221,800 shares $102,242.00 -27.6%N/A0.3 $4.69 10/15/202230,100 shares $144,480.00 -16.4%N/A0.9 $4.80 9/30/202236,000 shares $180,360.00 -45.4%N/A1 $5.01 9/15/202265,900 shares $392,764.00 -25.5%N/A1.6 $5.96 8/31/202288,400 shares $511,836.00 -18.8%N/A1.4 $5.79 8/15/2022108,800 shares $683,264.00 -22.6%N/A1.6 $6.28 7/31/2022140,600 shares $912,494.00 -44.2%N/A1.9 $6.49 7/15/2022252,000 shares $1.43 million -17.5%N/A2.7 $5.69 6/30/2022305,300 shares $1.72 million +13.6%N/A1.2 $5.65 6/15/2022268,700 shares $1.35 million -38.5%N/A1 $5.02 5/31/2022437,000 shares $2.34 million +5.1%N/A1.9 $5.35 5/15/2022415,800 shares $2.03 million +10.7%N/A1.8 $4.88 4/30/2022375,600 shares $2.12 million +50.0%N/A1.7 $5.65 4/15/2022250,400 shares $1.88 million +224.4%3.9%1.2 $7.51 3/31/202277,200 shares $310,344.00 +19.0%0.9%0.5 $4.02 3/15/202264,900 shares $262,845.00 -44.8%0.7%1.5 $4.05 2/28/2022117,500 shares $572,225.00 +36.3%1.2%2.4 $4.87 2/15/202286,200 shares $387,900.00 +9.1%0.9%1.6 $4.50 1/31/202279,000 shares $323,110.00 +5.6%0.8%1.3 $4.09 1/15/202274,800 shares $295,460.00 +4.0%0.8%1.2 $3.95 12/31/202171,900 shares $313,484.00 -5.8%0.8%1.2 $4.36 12/15/202176,300 shares $334,194.00 -1.0%0.8%1.4 $4.38 11/30/202177,100 shares $431,760.00 +2.5%0.8%1.4 $5.60 11/15/202175,200 shares $539,936.00 -51.4%0.9%1.5 $7.18 10/29/2021154,600 shares $1.13 million -3.6%1.8%3.3 $7.30 10/15/2021160,400 shares $1.26 million -20.9%1.9%3.4 $7.85 9/30/2021202,700 shares $1.85 million -0.3%2.3%4.2 $9.12 9/15/2021203,300 shares $1.68 million -3.1%2.4%2.9 $8.28 8/31/2021209,700 shares $1.50 million -11.0%2.4%2.5 $7.14 8/13/2021235,700 shares $1.64 million +1.3%2.7%2.1 $6.94 7/30/2021232,700 shares $1.50 million -2.8%2.7%1.9 $6.44Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/15/2021239,400 shares $1.78 million +0.3%2.8%1.9 $7.45 6/30/2021238,700 shares $1.92 million -43.6%2.8%1.8 $8.03 6/15/2021423,100 shares $3.88 million +17.9%4.9%3.6 $9.17 5/28/2021358,900 shares $2.58 million -13.2%4.1%3.4 $7.18 5/14/2021413,600 shares $3.09 million +14.1%4.8%4.6 $7.46 4/30/2021362,500 shares $3.69 million +10.9%4.4%2.4 $10.18 4/15/2021327,000 shares $3.56 million +4.1%3.9%2.1 $10.89 3/31/2021314,200 shares $3.51 million +11.3%3.8%2.1 $11.17 3/15/2021282,300 shares $3.95 million +15.4%3.4%1.8 $13.98 2/26/2021244,600 shares $3.42 million +73.6%3.1%1.3 $14.00 2/12/2021140,900 shares $1.86 million -1.4%1.8%0.7 $13.19 1/29/2021142,900 shares $1.53 million +9.3%1.8%1.1 $10.68 1/15/2021130,800 shares $1.43 million No Change1.6%1.1 $10.96 LYRA Short Interest - Frequently Asked Questions What is Lyra Therapeutics' current short interest? Short interest is the volume of Lyra Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,220,000 shares of LYRA short. 3.56% of Lyra Therapeutics' shares are currently sold short. Learn More on Lyra Therapeutics' current short interest. What is a good short interest ratio for Lyra Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYRA shares currently have a short interest ratio of 2.0. Learn More on Lyra Therapeutics's short interest ratio. Which institutional investors are shorting Lyra Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Lyra Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Lyra Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.56% of Lyra Therapeutics' floating shares are currently sold short. Is Lyra Therapeutics' short interest increasing or decreasing? Lyra Therapeutics saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 2,220,000 shares, a drop of 7.9% from the previous total of 2,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lyra Therapeutics' short interest compare to its competitors? 3.56% of Lyra Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Lyra Therapeutics: CollPlant Biotechnologies Ltd. (0.03%), PolyPid Ltd. (0.05%), Nexalin Technology, Inc. (2.16%), IRIDEX Co. (2.22%), Nephros, Inc. (0.12%), QT Imaging Holdings, Inc. (1.89%), NEXGEL, Inc. (1.64%), ReWalk Robotics Ltd. (5.25%), Vivos Therapeutics, Inc. (4.81%), Plus Therapeutics, Inc. (6.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Lyra Therapeutics stock? Short selling LYRA is an investing strategy that aims to generate trading profit from Lyra Therapeutics as its price is falling. LYRA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lyra Therapeutics? A short squeeze for Lyra Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LYRA, which in turn drives the price of the stock up even further. How often is Lyra Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYRA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies CollPlant Biotechnologies Short Interest Data PolyPid Short Interest Data Nexalin Technology Short Interest Data IRIDEX Short Interest Data Nephros Short Interest Data QT Imaging Short Interest Data NEXGEL Short Interest Data ReWalk Robotics Short Interest Data Vivos Therapeutics Short Interest Data Plus Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LYRA) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LYRA Stock Free LYRA Stock Alerts